Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-896-0 | CAS number: 100-86-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 (male/female) = 1280 mg/kg bw with 95% confidence limits of 934 -1770 mg/kg bw (equivalent or similar to OECD 401)
Read-across to PEA (CAS No. 60 -12 -8) - Acute inhalation toxicity: LC50 (male/female) = > 4.63 mg/L (nominal concentration) (Equivalent or similar to OECD 403/GLP)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Osborne-Mendel
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Fasting period before study: 18 hr prior to treatment
- Diet: Food was replaced in cages as soon as animals received their respective doses
- Water: ad libitum - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- No data
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- All animals were maintained under close observation for recording toxic signs and time of death. Such observation was continued until animals appeared normal and showed weight gain. The usual observation period was 2 weeks.
- Statistics:
- The LD50's, slope function, and their confidence limits were recorded. LD50'S were computed by the method of Litchfield & Wilcoxon.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 280 mg/kg bw
- 95% CL:
- > 934 - < 1 770
- Mortality:
- Death within 1 hour to 3 days
- Clinical signs:
- other: Depression within 10 min, coma within 1 hour.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 for acute oral toxicity of Dimethyl benzyl carbinol in Osborne-Mendel rats is 1280mg/kg bw with 95% confidence limits of 934-1770 mg/kg bw.
- Executive summary:
In an acute oral toxicity study (Jenner, 1964), Osborne Mendel rats (5/dose/sex) were given dimethyl benzyl carbinol and observed for 14 days.
Deaths occurred between 1 hr and 3 days. Depression was evident within 10 mins and coma within 1 hour.
The LD50 (male/female) is 1280 mg/kg bw with 95% confidence limits of 934 -1770 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Doses:
- 0.99, 1.48, 2.22, 3.33 and 5.00 g/kg
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 1.35 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1.02 - < 1.68
- Mortality:
- see Distribution of Mortality.
- Clinical signs:
- other: 0.99 g/kg: none; 1.48, 2.22 g/kg: depression, negative righting reflex; 3.33 g/kg: depression, piloerection, negative righting reflex; 5.00 g/kg: death within 3 hours.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 for acute oral toxicity of Dimethyl benzyl carbinol in rats is 1350mg/kg bw with 95% confidence limits of 1020-1680 mg/kg bw.
Referenceopen allclose all
Distribution of Mortality
Observation Day | |||||||||||||||
Dose g/kg |
Deaths/No. of animals | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
0.99 | 1/10 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1.48 | 6/10 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2.22 | 9/10 | 5 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
3.33 | 10/10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5.00 | 10/10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 280 mg/kg bw
- Quality of whole database:
- There are 2 studies available (equivalent or similar to OECD 401) and both have a Klimisch score of 2. The quallity of the database is medium.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Please see the read-across justification.
- Reason / purpose for cross-reference:
- read-across source
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 4.63 mg/L air (nominal)
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 1.38 mg/L air (analytical)
- Exp. duration:
- 4 h
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute inhalation study in Sprague-Dawley rats, the LC50 fro PEA was >4.63 mg/L (nominal concentration).
- Executive summary:
In an acute inhalation toxicity study (5692-07/14), a group of young adult Sprague Dawley strain rats (5/sex) were exposed to a test atmosphere of PEA for 4 hours (whole body) at a target concentration of 4.63 mg/L. Animals were then observed for 14 days.
LC50 male/female = > 4.63 mg/L (nominal concentration)
The mean achieved concentration was 1.38 ±0.19 mg/L (MMAD: 1.08 µm; GSD: 0.05). There were no deaths and no clinical changes of possible toxicological importance. Although small body weight losses occurred on the days following exposure the losses were generally made good by day 7 of the study. Focal grey-green areas observed grossly on the lungs were characterized histologically by aggregates of mononuclear leucocytes mainly about blood vassels· and air passages and occasionally extending to alveolar walls., some interstitial fibrosis and infiltration by foamy macrophages. These lesions were considered to be spontaneous and caused as a result of mild infection with murine respiratory mycoplasmosis. Pulmonary edema and mild congestion revealed in 3 rats could be attributed to euthanasia.
This acute inhalation toxicity test in rats is acceptable and satisfies the guideline requirement for an OECD 403 study.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 10th 1980 to 14th July 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- traditional method
- Limit test:
- yes
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source of test material: Research. Institute for Fragrance Materials, Englewood Cliffs, NJ. - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories Ltd., Wilmington, Mass, USA.
- Age at study initiation: approximately 8 weeks old
- Weight at study initiation: 175 to 225 g
- Fasting period before study:
- Housing: Housed individually in stainless steel, wire meshed-bottom cages
- Diet: Certified Purina Laboratory Rat Chow ad libitum
- Water: tap water ad libitum
ENVIRONMENTAL CONDITIONS (in inhalation chamber room)
- Temperature (°C): 22.3±0.29°C
- Humidity (%): 38.5±0.58% - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 1.08 µm
- Geometric standard deviation (GSD):
- 0.05
- Details on inhalation exposure:
- Inhalation Exposure Equipment
A 27" cube (400 liter volume) stainless steel whole body exposure chamber was utilized. A complete group of rats (5 males and 5 females) was housed in the chamber during treatment in a stainless steel wire mesh compartmentalized cage with each compartment being 7" X 3" X 4". Temperature and relative humidity in the inhalation chamber were. monitored hourly by means of remote sensors (YSI model 705 Temperature Probe and 91HC Dew Point Hygrometer) located inside the chamber. Air flow rate through the chamber was set at 45 L/min and was measured in the exhaust line by means of an orifice plate and Magnehelic differential pressure gauge. ' This arrangement in turn had been calibrated against a conventional balltype flow meter. The negative pressure within the chamber with respect to the room atmosphere was set at less than 0. 5 inches of water. Decontamination of chamber air was accomplished by passing the air through ~ HEPA filter, an activated charcoal filter arid a liquid scrubber prior to eliminating it from the facility.
Generation of Test Atmospheres
An aerosol of the test article was generated using a Thermo Systems Inc. six jet atomizer. The atomizer was used at a pressure of 9 psig with two jets in operation.
Exposure Procedure
After loading into the chamber the test animals were exposed to an aerosol of the test article for a single period of four hours. Nominal chamber concentrations were calculated from the weight loss from the atomizer and total airflow through.the chamber during the exposure period.
Measurement of Chamber Concentration and Particle Size Distribution
Hourly air samples for measurement of chamber concentration were drawn from the chamber, at a rate of 5 L/min for two minutes, through a preweighed Gelman glass fibre filtet paper in a Gelman in-line filter holder. Chamber concentration was calculated from the increase in weight of the filter and volume of air sample. Hourly air samples from the inhalation chamber for particle size analysis were withdrawn and passed through a Casella Cascade Impactor. The distribution and size of particles which deposited on each of the four stages of the Impactor were determined by light microscopy. The method was originally described in Cascade Impactor Casella leaflet 3018/RT and was modified in this laboratory (see Bio Standard Operating Procedures No. I AC 01, 02 and 04) to include the following procedures:
1) Circular cover-slips upon which the aerosol had been impacted were mounted on a slide and examined microscopically.
2) A representative region of eaqh slide was selected for analysis.
3) An observing field of 0.47 mm X 0.47 mm (square grid) under 400 X magnification was superimposed on 'the region selected.
4) All particles falling within this grid were observed with a calibrated filar micrometer eyepiece and the numbers falling into various size ranges were recorded.
5) The numbers of particles in each size range were plotted against particle size on log probability graph paper. The line of best fit was drawn and the geometric mean particle size and its standard deviation calculated. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Nominal concentration of 4.63 mg/L
Measured chamber concentration of 1.38 mg/L ±0.19 - No. of animals per sex per dose:
- 5 males
5 females - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: All animals were observed closely during and immediately after exposure, and at least twice daily during the 14 day recovery period.
- Frequency of observations and weighing: Each animal was weighed on the_ day of exposure and on days 2, 3, 4, 7 and 14 of the study.
- Necropsy of survivors performed: Yes. All animals were killed 14 days. after exposure by intraperitoneal injection of Hoechst T-61 euthanasia solution and examined macroscopically. Liver and kidneys were preserved in 10% buffered formalin solution. Lungs were preserved by perfusion with the fixative. Bronchial lymph nodes were examined macroscopically but not retained·for histological assessment. All other macroscopically abnormal tissues were preserved.
- Histopathology: Samples of lung, liver, kidney and any macroscopic abnormality, from all animals were fixed in formalin for at least 48 hours, routinely processsed, embedded in paraffin wax stained with haematoxylin and eosin and examined microscopically. - Statistics:
- Mean and standard deviatl6n will be determined for chamber temperature and humidity. In addition, animal. body weight will also be tabula.ted.
Clinical findings and gross and histopathological observations will be summarized in incidence tables. - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 4.63 mg/L air (nominal)
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 1.38 mg/L air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- There were no deaths.
- Clinical signs:
- other: There were no clinical changes of possible toxicological importance.
- Body weight:
- Although small body weight losses occurred on the days following exposure the losses were generally made good by day 7 of the study. Body weight gains during the second week of the observation period were considered to be satisfactory.
- Gross pathology:
- Focal grey-green areas observed grossly on the lungs were characterized histologically by aggregates of mononuclear leucocytes mainly about blood vassels· and air passages and occasionally extending to alveolar walls., some interstitial fibrosis and infiltration by foamy macrophages. These lesions were considered to be spontaneous and caused as a result of mild infection with murine respiratory mycoplasmosis. Pulmonary edema and mild congestion revealed in 3 rats could be attributed to euthanasia.
- Other findings:
- - Histopathology: There were no treatment related changes.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute inhalation study in Sprague-Dawley rats, the LC50 fro PEA was >4.63 mg/L (nominal concentration).
- Executive summary:
In an acute inhalation toxicity study (5692-07/14), a group of young adult Sprague Dawley strain rats (5/sex) were exposed to a test atmosphere of PEA for 4 hours (whole body) at a target concentration of 4.63 mg/L. Animals were then observed for 14 days.
LC50 male/female = > 4.63 mg/L (nominal concentration)
The mean achieved concentration was 1.38 ±0.19 mg/L (MMAD: 1.08 µm; GSD: 0.05). There were no deaths and no clinical changes of possible toxicological importance. Although small body weight losses occurred on the days following exposure the losses were generally made good by day 7 of the study. Focal grey-green areas observed grossly on the lungs were characterized histologically by aggregates of mononuclear leucocytes mainly about blood vessels and air passages and occasionally extending to alveolar walls., some interstitial fibrosis and infiltration by foamy macrophages. These lesions were considered to be spontaneous and caused as a result of mild infection with murine respiratory mycoplasmosis. Pulmonary edema and mild congestion revealed in 3 rats could be attributed to euthanasia.
This acute inhalation toxicity test in rats is acceptable and satisfies the guideline requirement for an OECD 403 study.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 4.63 mg/m³ air
- Quality of whole database:
- There is one acute inhalation toxcity study available (read-across to PEA, CAS No. 60-12-8). The quallity of the database is medium.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
There are two acute oral toxicity studies in rats available.
In the acute oral toxicity supporting study, (equivalent or similar to OECD 401; RIFM 1973), the LD50 for acute oral toxicity of dimethyl benzyl carbinol in rats is 1350mg/kg bw with 95% confidence limits of 1020-1680 mg/kg bw.
In the acute oral toxicity key study (equivalent or similar to OECD 401; Jenner, 1964), Osborne Mendel rats (5/dose/sex) were given dimethyl benzyl carbinol and observed for 14 days. Deaths occurred between 1 hr and 3 days. Depression was evident within 10 mins and coma within 1 hour. The LD50 (male/female) is 1280 mg/kg bw with 95% confidence limits of 934 -1770 mg/kg bw.
Acute inhalation toxicity
There is no acute inhalation toxicity study available for dimethyl benzyl carbinol. Read-across was performed to an acute inhalation toxicity study in rats from PEA (CAS No. 60 -12 -8).
In an acute inhalation toxicity study (equivalent or similar to OECD 403/GLP), a group of young adult Sprague Dawley strain rats (5/sex) were exposed to a test atmosphere of PEA for 4 hours (whole body) at a target concentration of 4.63 mg/L. Animals were then observed for 14 days. The mean achieved concentration was 1.38 ±0.19 mg/L (MMAD: 1.08 µm; GSD: 0.05). There were no deaths and no clinical changes of possible toxicological importance. Although small body weight losses occurred on the days following exposure the losses were generally made good by day 7 of the study. Focal grey-green areas observed grossly on the lungs were characterized histologically by aggregates of mononuclear leucocytes mainly about blood vessels and air passages and occasionally extending to alveolar walls., some interstitial fibrosis and infiltration by foamy macrophages. These lesions were considered to be spontaneous and caused as a result of mild infection with murine respiratory mycoplasmosis. Pulmonary edema and mild congestion revealed in 3 rats could be attributed to euthanasia. The LC50 (male/female) was > 4.63 mg/L (nominal concentration)
Justification for classification or non-classification
Based on the available information in the dossier, the substance DMBC (CAS No. 100-86-7) does need to be classified for acute toxicity for the oral route (Category 4) and does not need to be classified for acute toxicity or specific target organ toxicity - single exposure for the inhalation route, when the criteria outlined in Annex I of 1272/2008/EC are applied.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)